News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
March 13, 2023
RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing
Announcements
February 9, 2023
Repligen Appoints Martin D. Madaus to Board of Directors
Announcements
September 19, 2022
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement.
Announcements
February 15, 2022
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
Announcements
December 16, 2021
Repligen Acquires BioFlex Solutions, LLC
Announcements
November 5, 2021
Repligen Releases Inaugural Sustainability Report
Announcements
September 16, 2021
Repligen Announces Agreement to Acquire Avitide Inc
Announcements
September 9, 2021
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
Announcements
September 3, 2021
Repligen Extends Long Term Supply Agreement with Cytiva for Affinity Ligands
News
July 26, 2021
Repligen Corporation set to significantly expand bioprocessing manufacturing capactiy and create 130+ new jobs in Waterford
IDA Ireland
Announcements
June 22, 2021
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
News
June 13, 2021
Repligen buys French filtration firm Polymem
Dan Stanton BioProcess International